Strategic partnerships Tecan’s active collaboration with major industry players and recent partnerships with HP, BioSkryb, and CUTISS present opportunities to position complementary automation and liquid handling solutions alongside co-developed workflows for high-value customers in cell therapy, single-cell sequencing, and regenerative medicine.

Automation leadership With a strong reputation as a global leader in laboratory automation and the launch of Veya, Tecan is well positioned to upsell advanced liquid handling platforms and scalable automation to mid- to large-size labs seeking efficiency, precision, and compliance across high-throughput workflows.

High‑growth markets Recent news highlights engagement in single-cell sequencing, high-throughput library preparation, and clinical biotech collaborations, indicating growing demand for automated, reproducible workflows in life sciences and diagnostics that we can target with integrated hardware, software, and service packages.

Digital & data capabilities Tecan’s tech stack and SAP-based tools suggest an opportunity to offer data integration, lab informatics, and analytics solutions that optimize instrument management, sample tracking, and provenance across multi-site operations for pharma, CROs, and academia.

Financially scalable With revenue in the mid-range for the sector and a broad installed base, there is appetite for upgrade proposals, service contracts, and consumables that lock in recurring revenue while expanding footprint in automation across life science and clinical laboratories.